These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33983602)

  • 1. Malignant Phyllodes of Breast.
    Yom CK
    Adv Exp Med Biol; 2021; 1187():601-612. PubMed ID: 33983602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation Study of the Newly Proposed Refined Diagnostic Criteria for Malignant Phyllodes Tumor With 136 Borderline and Malignant Phyllodes Tumor Cases.
    Li X; Nguyen TTA; Zhang J; Nayak A; Liu Y; Duckworth LA; Zhang G; Bakkar R; Agarwal I; Hou Y; Guo H; Huang X; Wei S; Yasmeen S; Khoury T; Huang H; Zhang H; Smith GH; Turashvili G; Peng L; Liu Y; Yang W; Siziopikou KP
    Am J Surg Pathol; 2024 Sep; 48(9):1146-1153. PubMed ID: 38934254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.
    Taira N; Takabatake D; Aogi K; Ohsumi S; Takashima S; Nishimura R; Teramoto N
    Jpn J Clin Oncol; 2007 Oct; 37(10):730-6. PubMed ID: 17932112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical treatment of phyllodes tumors of the breast: retrospective review of 172 cases.
    Chen WH; Cheng SP; Tzen CY; Yang TL; Jeng KS; Liu CL; Liu TP
    J Surg Oncol; 2005 Sep; 91(3):185-94. PubMed ID: 16118768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases.
    Di Liso E; Bottosso M; Lo Mele M; Tsvetkova V; Dieci MV; Miglietta F; Falci C; Faggioni G; Tasca G; Giorgi CA; Giarratano T; Mioranza E; Michieletto S; Saibene T; Dei Tos AP; Conte P; Guarneri V
    ESMO Open; 2020 Oct; 5(5):e000843. PubMed ID: 33020219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of phyllodes tumor: A systematic review and meta-analysis of real-world evidence.
    Yu CY; Huang TW; Tam KW
    Int J Surg; 2022 Nov; 107():106969. PubMed ID: 36328344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
    Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
    Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
    Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
    Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary treatment of cystosarcoma phyllodes of the breast.
    Chaney AW; Pollack A; McNeese MD; Zagars GK; Pisters PW; Pollock RE; Hunt KK
    Cancer; 2000 Oct; 89(7):1502-11. PubMed ID: 11013364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
    Nie Y; Chen J; Huang D; Yao Y; Chen J; Ding L; Zeng J; Su S; Chao X; Su F; Yao H; Hu H; Song E
    Cancer Res; 2017 Jul; 77(13):3605-3618. PubMed ID: 28512246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08).
    Choi N; Kim K; Shin KH; Kim Y; Moon HG; Park W; Choi DH; Kim SS; Ahn SD; Kim TH; Chun M; Kim YB; Kim S; Choi BO; Kim JH
    Breast Cancer Res Treat; 2018 Sep; 171(2):335-344. PubMed ID: 29808288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phyllodes tumors of the breast: the role of pathologic parameters.
    Tan PH; Jayabaskar T; Chuah KL; Lee HY; Tan Y; Hilmy M; Hung H; Selvarajan S; Bay BH
    Am J Clin Pathol; 2005 Apr; 123(4):529-40. PubMed ID: 15743740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phyllodes tumours of the breast: Outcomes and recurrence after excision.
    Wen B; Mousadoust D; Warburton R; Pao JS; Dingee C; Chen L; McKevitt E
    Am J Surg; 2020 May; 219(5):790-794. PubMed ID: 32145921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes After Surgical Treatment of Malignant/Borderline Phyllodes Tumors of the Breast.
    Spanheimer PM; Murray MP; Zabor EC; Stempel M; Morrow M; Van Zee KJ; Barrio AV
    Ann Surg Oncol; 2019 Jul; 26(7):2136-2143. PubMed ID: 30783853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
    Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
    Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.
    Tan PH; Thike AA; Tan WJ; Thu MM; Busmanis I; Li H; Chay WY; Tan MH;
    J Clin Pathol; 2012 Jan; 65(1):69-76. PubMed ID: 22049216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
    Gong C; Nie Y; Qu S; Liao JY; Cui X; Yao H; Zeng Y; Su F; Song E; Liu Q
    Cancer Res; 2014 Aug; 74(16):4341-52. PubMed ID: 24980553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological study on phyllodes tumor of the breast.
    Shi F; Ye H; Chai Z;
    Zhonghua Bing Li Xue Za Zhi; 2002 Jun; 31(3):208-12. PubMed ID: 12475436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of phyllodes breast tumors.
    Guillot E; Couturaud B; Reyal F; Curnier A; Ravinet J; Laé M; Bollet M; Pierga JY; Salmon R; Fitoussi A;
    Breast J; 2011; 17(2):129-37. PubMed ID: 21251125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.